Ensayos clínicos

Inclusion Criteria

• Primary care provider is participating in trial
• Adult, ≥ 18 years
• Has type 2 diabetes
• English speaking
• Recognize primary care provider as main diabetes care provider
• Can state is available for follow-up for six months after treatment decision
• Specific for diabetes medication
  • Clinical diagnosis of type 2 diabetes for one year or more (c-peptide test is not required)
  • Use 0, 1, or 2 oral hypoglycemic agents at maximum doses
  • Stable but inadequate glycemic control or worsening glycemic control as identified by most recent HbA1c measure over 7.3% within 12 months of the time of eligibility 
  • Identified by provider as a medically-appropriate candidate for diabetes medications, (i.e. no contraindications to taking the medications, e.g., allergy)
• Specific for cardiovascular medication
  • Clinical diagnosis of type 2 diabetes for any duration (c-peptide test is not required)
  • Identified by provider as a medically-appropriate candidate for statins, (i.e. no contraindications to taking the medications, e.g., allergy)

Exclusion Criteria

• Major barriers to providing written informed consent and  participating in shared decision making (i.e. severe vision or hearing impairment, cognitive impairment, non-English speaking)
• Specific for diabetes medication
  • Use insulin therapy
• Specific for cardiovascular medication
• Use a statin currently